Ocuphire Pharma, Inc. (OCUP)
NASDAQ: OCUP · IEX Real-Time Price · USD
1.540
+0.030 (1.99%)
At close: Apr 23, 2024, 4:00 PM
1.510
-0.030 (-1.95%)
After-hours: Apr 23, 2024, 7:31 PM EDT
Ocuphire Pharma Stock Forecast
OCUP's stock price has decreased by -71.22% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Ocuphire Pharma stock have an average target of 19, with a low estimate of 17 and a high estimate of 20. The average target predicts an increase of 1,133.77% from the current stock price of 1.54.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 20, 2024.
Analyst Ratings
The average analyst rating for OCUP stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $24 → $20 | Strong Buy | Maintains | $24 → $20 | +1,198.70% | Mar 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +1,198.70% | Mar 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +1,198.70% | Nov 14, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $17 | Buy | Reiterates | $17 | +1,003.90% | Aug 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +1,198.70% | Aug 14, 2023 |
Financial Forecast
Revenue This Year
26.56M
from 19.05M
Increased by 39.44%
Revenue Next Year
67.40M
from 26.56M
Increased by 153.74%
EPS This Year
-0.31
from -0.46
EPS Next Year
1.05
from -0.31
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 55.0M | 188.4M | 66.4M | 102.8M | 138.6M |
| Avg | 26.6M | 67.4M | 43.3M | 77.6M | 120.5M |
| Low | 14.8M | 20.7M | 10.7M | 53.2M | 102.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 189.0% | 609.4% | -1.4% | 137.5% | 78.5% |
| Avg | 39.4% | 153.7% | -35.8% | 79.3% | 55.2% |
| Low | -22.3% | -22.2% | -84.2% | 22.9% | 31.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.12 | 6.09 | 0.68 | 1.28 | 2.02 |
| Avg | -0.31 | 1.05 | -0.17 | -0.22 | 0.81 |
| Low | -0.88 | -0.49 | -1.90 | -1.63 | -0.33 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | -34.8% | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.